Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis

NCT06016517 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Etanercept
DRUG: Adalimumab
DRUG: Upadacitinib
DRUG: Tocilizumab

Sponsor

Tufts Medical Center